|
|
Northwest Biotherapeutics Inc.
|
 |
||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
|
return to message board, top of board |
Re: O'Brien-Fleming spendinf function-HodagThe company already knows a submission won't get to ADCOM which is why they say they will submit with MHRA. It's all window dressing to keep LP's money train rolling. They'll blame conspiracies and BP just like they always have. FDA Ad Comm is typically not utilized when the data clearly support or clearly does not support the safety and effectiveness of the therapy under investigation. It doesn't take an ADCOM to see the ECA is post-hoc bullshit and doesn't meet the basic FDA requirements for an ECA regardless of what the flippers and GaryMs of the world hope, believe, and pray. |
||||||||||||
|
|
return to message board, top of board |
| Msg # | Subject | Author | Recs | Date Posted |
| 16750 | Re: O'Brien-Fleming spendinf function-Hodag | GaryM | 5 | 9/21/2023 6:09:16 PM |
